Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma
Public ClinicalTrials.gov record NCT00002767. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
PHASE III TRIAL OF MELACINE PLUS INTERFERON ALFA-2B VERSUS INTERFERON ALFA-2B IN PATIENTS WITH DISSEMINATED MALIGNANT MELANOMA
Study identification
- NCT ID
- NCT00002767
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- GlaxoSmithKline
- Industry
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Interventions
- Detox-B adjuvant Biological
- recombinant interferon alfa Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 1995
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jan 5, 2014
Started 1996
United States locations
- U.S. sites
- 27
- U.S. states
- 15
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama Comprehensive Cancer Center | Birmingham | Alabama | 35294 | — |
| Beckman Research Institute, City of Hope | Duarte | California | 91010 | — |
| University of California San Diego Cancer Center - La Jolla | La Jolla | California | 92093-0686 | — |
| Kaiser Permanente Medical Center - Oakland | Oakland | California | 94611 | — |
| Kaiser Permanente Medical Center-Sacramento | Sacramento | California | 95825 | — |
| UCSF Cancer Center and Cancer Research Institute | San Francisco | California | 94115-0128 | — |
| Kaiser Permanente Medical Group - San Francisco | San Francisco | California | 94115 | — |
| Kaiser Permanente Medical Center - Santa Clara | Santa Clara | California | 95051-5386 | — |
| Kaiser Permanente Medical Center - Vallejo | Vallejo | California | 94589 | — |
| University of Connecticut Health Center | Farmington | Connecticut | 06360-7106 | — |
| Yale Comprehensive Cancer Center | New Haven | Connecticut | 06520-8028 | — |
| Sylvester Cancer Center, University of Miami | Miami | Florida | 33136 | — |
| Adventist Health System/Sunbelt, Inc. | Orlando | Florida | 32803 | — |
| Emory University School of Medicine | Atlanta | Georgia | 30322 | — |
| Lutheran General Cancer Care Center | Park Ridge | Illinois | 60068 | — |
| University of Louisville Hospital | Louisville | Kentucky | 40202 | — |
| Creighton University Cancer Center | Omaha | Nebraska | 68131-2197 | — |
| Norris Cotton Cancer Center | Lebanon | New Hampshire | 03756 | — |
| University of New Mexico Cancer Research & Treatment Center | Albuquerque | New Mexico | 87131 | — |
| Interlakes Oncology/Hematology PC | Rochester | New York | 14623 | — |
| Duke Comprehensive Cancer Center | Durham | North Carolina | 27710 | — |
| Barrett Cancer Center, The University Hospital | Cincinnati | Ohio | 45219 | — |
| Christ Hospital | Cincinnati | Ohio | 45219 | — |
| CCOP - Columbus | Columbus | Ohio | 43206 | — |
| Hematology Oncology Consultants Inc | Columbus | Ohio | 43235 | — |
| Oregon Cancer Center at Oregon Health Sciences University | Portland | Oregon | 97201-3098 | — |
| Southwest Regional Cancer Center | Austin | Texas | 78705 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00002767, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 5, 2014 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00002767 live on ClinicalTrials.gov.